Survey shows breakthrough medical research relies heavily on NIH funding

A survey highlighting the correlation between today's cutting edge medical research and the National Institutes of Health (NIH) funding was released today at the 54th Annual Meeting of the American Society of Hematology (ASH), the preeminent medical meeting for physicians and scientists in hematology that draws more than 20,000 attendees from around the world. The survey, representing responses from 1,040 abstract presenters from the U.S. and abroad, demonstrates how critical NIH funding has been to the success of science and medicine.

"Every year researchers and doctors across the globe look to the ASH annual meeting for breakthrough science," said ASH President-Elect Janis Abkowitz, MD of the University of Washington School of Medicine in Seattle. "With nearly two-thirds of the U.S. presenters at this year's annual meeting reporting that they rely on NIH funding, this survey shows unequivocally that those breakthroughs depend on NIH investment."

also show that in addition to funding current research, a greater number – 86 percent of American abstract presenters – report that they had referenced an NIH-funded study for their own research over the course of their careers. In addition, the survey reveals a high level of concern among scientists and physicians about the impact of reduced NIH funding. Of the U.S. respondents, 75 percent said that when it comes to and development, they are "extremely concerned" (responses on a scale from 1 = not concerned to 5 = extremely concerned) about the threat of NIH and the impact on their future careers.

"As a young investigator, I am dependent on the NIH to help fund my research," said ASH member Manali Patel, MD, MPH, a Postdoctoral /Oncology Medical Fellow at Stanford University who focuses on cancer quality and research. "I love my research and would love to continue it, but am unsure where the direction of research funding is heading and very wary of the impact of NIH funding on my future career."

The survey also shows that the impact of NIH goes well beyond U.S. borders. In fact, 52 percent of international presenters said that they have referenced an NIH-funded study for their own research and 22 percent report being "extremely concerned" about the threat of NIH budget cuts.

add to favorites email to friend print save as pdf

Related Stories

Can disclosure hurt the translation of research?

Sep 19, 2012

All major clinical trials now include disclosures detailing who funded the study to ensure transparency. However, is it possible that this transparency is actually hurting research? One might assume that the methodological ...

Recommended for you

Using feminist theory to understand male rape

3 hours ago

Decades of feminist research have framed rape and sexual assault as a 'women's issue', leaving little room for the experiences of male victims. But a new study published in the Journal of Gender Studies suggests that feminist ...

Simulation-based training improves endoscopy execution

Oct 18, 2014

(HealthDay)—Simulation-based training (SBT) improves clinicians' performance of gastrointestinal endoscopy in both test settings and clinical practice, according to research published in the October issue ...

Data sharing in pharmaceutical industry shows progress

Oct 16, 2014

To enhance the transparency of clinical trials for new drugs, a number of pharmaceutical firms have begun sharing data with investigators outside their own companies. Brian L. Strom, chancellor of Rutgers Biomedical and Health ...

Swiss drug maker Roche posts flat 3Q sales

Oct 16, 2014

(AP)—Swiss drugmaker Roche Holding AG has reported "stable" or flat sales for the first nine months of 2013 but says the results show strong demand for its cancer drugs and emerging new products.

User comments